ONCY
Companies
NASDAQ
Oncolytics Biotech Inc.
Health Care
$0.74
-$0.22 (-24.18%)
Price Chart
Overview
About ONCY
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
Market Cap
$79.2M
Volume
197.3K
Avg. Volume
191.2K
P/E Ratio
-1.6333333
Dividend Yield
0.00%
Employees
30.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.01
Moderate Correlation
Volatility
High (0.72)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ONCY shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$79.2M
Volume197.3K
P/E Ratio-1.63
Dividend Yield0.00%
Important Dates
Next Dividend
May 25, 2018Next Earnings
March 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025